GuidelineAmerican journal of respiratory and critical care medicine2025
Approach to the Evaluation and Management of Interstitial Lung Abnormalities: An Official American Thoracic Society Clinical Statement.
Erratum issuedAbstract readPractice GuidelineReview
In one paragraph
Guideline in American journal of respiratory and critical care medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 56 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
56 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Clinical practice guideline for the diagnosis of granulomatous-lymphocytic interstitial lung disease in patients with common variable immunodeficiency disorders: an ERS Clinical Research Collaboration.The European respiratory journal · 2026Guideline
- Cause of death in fibrotic and nonfibrotic interstitial lung abnormalities: the MESA study.American journal of respiratory and critical care medicine · 2026Article
- Acute exacerbation in fibrotic interstitial lung disease: an international working group report.American journal of respiratory and critical care medicine · 2026Review
- Contemporary Concise Review 2025: Interstitial Lung Disease.Respirology (Carlton, Vic.) · 2026Review
- Occurrence of progressive pulmonary fibrosis and its association with survival in connective tissue disease-associated interstitial lung disease: an international retrospective cohort study.Rheumatology international · 2026Article
- Observational
- Prognostic value of AI-derived probability of interstitial lung abnormalities and interstitial lung disease in patients with esophageal cancer.Japanese journal of radiology · 2026Article
- Pleural plaques and interstitial lung abnormalities in AGES-Reykjavik study.ERJ open research · 2026Article
- Clinical characteristics and factors associated with progressive pulmonary fibrosis in patients with systemic sclerosis-associated interstitial lung disease.Clinical rheumatology · 2026Article
- Chest CT imaging toward personalized management of chronic obstructive pulmonary disease, asthma, and bronchiectasis: pulmonologist perspectives.Japanese journal of radiology · 2026Review
- CT quantification of interstitial lung abnormalities: a prospective comparison between supine and prone positions.European radiology · 2026Article
- Letter to the Editor: CT-guided lung biopsy in patients with interstitial lung abnormalities.European radiology · 2026Article
- Fibrotic Interstitial Lung Abnormalities on Preoperative CT Images Predict Cause-Specific Mortality after Stage I Non-Small Cell Lung Cancer Resection.Annals of surgical oncology · 2026Article
- Automated identification of interstitial lung abnormalities in lung screening using quantitative CT.BMJ open respiratory research · 2026Article
- Interstitial lung disease in metastatic breast cancer: a landscape review using SEER-Medicare.Breast cancer research and treatment · 2026Article
- Critical dialogue: Interstitial lung abnormalities: an evolving concept.Insights into imaging · 2026Article
- From ideal respiratory health to chronic lung disease: indicators of impaired respiratory health.Expert review of respiratory medicine · 2026Review
- Advances in pharmacotherapy for fibrotic interstitial lung disease.Medical review (2021) · 2026Review
- Development and validation of a clinical factor-based nomogram for predicting imaging-defined cardiopulmonary abnormality risk in an asymptomatic screening population.World journal of radiology · 2026Article
- The evolving comorbidity landscape of rheumatoid arthritis.Nature reviews. Rheumatology · 2026Review
Corrections and comments
- Erratum issued
Authors and funding
40 authors.
Anna J PodolanczukORCID 0000-0002-9559-1485
Gary M HunninghakeORCID 0000-0001-9782-2841
Kevin C WilsonORCID 0000-0003-4429-2263
Yet H KhorORCID 0000-0002-5434-9342
Fayez KheirORCID 0000-0002-4192-5080
Brandon PangORCID 0000-0001-9223-344X
Ayodeji AdegunsoyeORCID 0000-0002-7015-9610
Gretchen Cararie
Tamera J CorteORCID 0000-0002-5076-8929
Jim Flanagan
Gunnar GudmundssonORCID 0000-0002-7251-8322
Lida P HaririORCID 0000-0002-6190-624X
Hiroto HatabuORCID 0000-0003-1436-2988
Stephen M HumphriesORCID 0000-0002-5113-4530
Bhavika KaulORCID 0000-0003-1325-8820
John S KimORCID 0000-0002-8887-150X
Melanie KonigshoffORCID 0000-0001-9414-5128
Jonathan A KropskiORCID 0000-0002-8923-1344
Joyce S LeeORCID 0000-0002-5758-8365
Fengming LuoORCID 0000-0001-9267-3437
David A LynchORCID 0000-0002-6329-2325
Fernando J MartinezORCID 0000-0002-2412-3182
Sydney B Montesi
Yuben MoodleyORCID 0000-0002-0777-1196
Justin M OldhamORCID 0000-0003-4957-8869
Sara PiciucchiORCID 0000-0001-6608-0574
Rachel K PutmanORCID 0000-0002-8027-7450
Luca RicheldiORCID 0000-0001-8594-1448
Ivan O Rosas
Margaret L SalisburyORCID 0000-0001-8217-6955
Mary M Salvatore
Moises SelmanORCID 0000-0002-1022-4783
Joon Beom SeoORCID 0000-0003-0271-7884
Jin Woo SongORCID 0000-0001-5121-3522
Carey C ThomsonORCID 0000-0002-5861-0683
Marina Vivero
Louise V WainORCID 0000-0003-4951-1867
Marlies WijsenbeekORCID 0000-0002-4527-6962
David A SchwartzORCID 0000-0001-6743-8443
Christopher J RyersonORCID 0000-0003-1049-393X
Funding
Project 4: Defining the Molecular Natural History of Early and Progressive Pulmonary FibrosisP01HL172729 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Nicholas Eli Banovich · 2024 to 2026
$11.2MClinical Genetics and Screening for Pulmonary FibrosisR01HL130974 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI GARY MATTHEW HUNNINGHAKE, Benjamin Alexander Raby · 2016 to 2026
$10.0MGenetic and Genomic Characterization of the Occurrence and Progression of Interstitial Lung AbnormalitiesR01HL135142 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI MICHAEL H. CHO, GARY MATTHEW HUNNINGHAKE · 2017 to 2026
$7.7MInterstitial Lung Abnormalities: Defining the Phenotype, Causes, and Consequences.R01HL111024 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI HUNNINGHAKE, GARY MATTHEW · 2013 to 2022
$6.4MGenes and Transcripts that Interact with MUC5B in Pulmonary FibrosisR01HL149836 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI CLOUTHIER, DAVID E., SCHWARTZ, DAVID ALBERT · 2020 to 2023
$3.0MProteomic Profiling of Idiopathic Pulmonary Fibrosis Progression TrajectoryR01HL169166 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Justin M Oldham · 2023 to 2026
$2.7MPrognostic Biomarker Development in Progressive Fibrosing Interstitial Lung DiseaseR01HL166290 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Justin M Oldham · 2024 to 2026
$2.2MReconceptualizing Disease Progression in Pulmonary FibrosisR01HL179065 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Margaret Louise Salisbury · 2025 to 2026
$1.5MVascular Leak and Outcomes in IPFK23HL150331 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI MONTESI, SYDNEY · 2020 to 2024
$887kDefining the biologic and physiologic trajectory of presymptomatic through advanced pulmonary fibrosisR56HL166941 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SALISBURY, MARGARET LOUISE · 2023 to 2023
$768kNHLBI NIH HHS K23 HL150331NHLBI NIH HHS P01 HL172729NHLBI NIH HHS R01 HL111024NHLBI NIH HHS R01 HL130974NHLBI NIH HHS R01 HL135142NHLBI NIH HHS R01 HL149836NHLBI NIH HHS R01 HL166290NHLBI NIH HHS R01 HL169166NHLBI NIH HHS R01 HL179065NHLBI NIH HHS R56 HL166941Wellcome Trust
Abstract
PubMed holds no abstract for this paper.
Indexed as
Lung Diseases, InterstitialDiagnosis, DifferentialHumansLungSocieties, MedicalTomography, X-Ray ComputedUnited Statescomputed tomographyinterstitial lung abnormalities (ILA)interstitial lung disease (ILD)pulmonary fibrosisscreening
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.